Mekheal Nader, Roman Sherif, Michael Patrick
Internal Medicine, St. Joseph's University Medical Center, Paterson, USA.
Cureus. 2021 Feb 7;13(2):e13207. doi: 10.7759/cureus.13207.
Since the coronavirus (COVID-19) pandemic started, new challenges have emerged regarding the management of coronavirus-infected patients. One of the most known devastating complications associated with COVID-19 is hypercoagulability. This can lead to severe disability or even death, especially in critically ill patients with known chronic comorbidities such as hypertension (HTN) and diabetes. D-dimer and clinical condition are among the most important tools currently used by clinicians to guide therapy and anticoagulation prophylaxis. Here we present a case of a COVID-19-infected patient with no known comorbidities and mild elevation in initial D-dimer level who had a rapid deterioration ultimately leading to death within weeks of admission.
自冠状病毒(COVID-19)大流行开始以来,冠状病毒感染患者的管理出现了新的挑战。与COVID-19相关的最著名的毁灭性并发症之一是高凝状态。这可能导致严重残疾甚至死亡,尤其是在患有高血压(HTN)和糖尿病等已知慢性合并症的重症患者中。D-二聚体和临床状况是临床医生目前用于指导治疗和抗凝预防的最重要工具之一。在此,我们报告一例COVID-19感染患者,该患者无已知合并症,初始D-二聚体水平轻度升高,入院数周内病情迅速恶化,最终导致死亡。